Benefit from alternate-day prednisone in myasthenia gravis.
D000200:Action Potentials / Q000187:drug effects; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000503:physiopathology; D009157:Myasthenia Gravis / Q000188:drug therapy* / Q000503:physiopathology; D009469:Neuromuscular Junction / Q000187:drug effects; D011241:Prednisone / Q000008:administration & dosage* / Q000494:pharmacology; D012075:Remission, Spontaneous; D009435:Synaptic Transmission / Q000187:drug effects; D013997:Time Factors
D011241:Prednisone